Research Article

The Progress of Thyroid Cancer in The Covid 19 Period

Volume: 44 Number: 2 June 30, 2022
EN

The Progress of Thyroid Cancer in The Covid 19 Period

Abstract

Objective: To evaluate the effect of the COVID-19 pandemic on the thyroid cancer stage.
Methods : Our study includes a comparative analysis of two patient groups treated for thyroid cancer. Patients who were treated for thyroid cancer between 11 April 2018 and 11 March 2020 were included in Group 1, and patients who were treated for thyroid cancer between 11 March 2020 and 11 February 2022 during the COVID-19 epidemic were included in Group 2.
Results: Groups 1 and 2 included 163 and 117 patients, respectively. Patients with preoperative fine-needle aspiration biopsy (FNAB) as potentially malignant or malignant were significantly higher in Group 2 (p=0.001). When compared according to the postoperative pathological diagnoses, there was a significant difference between the groups, poorly differentiated thyroid cancer was more common in Group 2 (p=0.018). Pathological tumour diameter was significantly larger in Group 2 (p=0.001).
Conclusions: Patients with suspicious findings in terms of thyroid diseases and cancer applied to the hospital later, both because of the fear of contracting COVID-19 and as a result of the pandemic measures recommended and implemented by all world health authorities. These patients applied to the hospital with their complaints gradually increasing in the following periods, parallel to this, there was a delay in the diagnosis of thyroid cancer and the disease could be detected at a more advanced stage.

Keywords

References

  1. 1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;18:2164-2167. https://doi.org/10.1001/jama.295.18.2164.
  2. 2. Adas G, Adas M, Özülker F, Akçakaya A. Thyroid Cancers. Okmeydanı Med J, 2012, 28: 26-34. https://doi.org/10.5222/otd.supp1.2012.026.
  3. 3. Jameson JL, De Groot JL. Endocrinology adult and pediatric. In: Pacini F, Marchisotta S, De Groot JL. Thyroid neoplasia. Saunders Elsevier, 6th edition, Philadelphia 2010:1668-1701.
  4. 4. World Health Organization. Pneumonia of Unknown Cause- China. WHO; 2020. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/. Accessed in 2020 (April 3).
  5. 5. Chan Jasper FW, Yuan SF, Kok KH, To Kelvin KW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2019; 395: 514– 23. https://doi.org/ 10.1016/S0140-6736(20)30154-9.
  6. 6. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19. WHO; 2020. Available from: https:// www.who.int/director-general/speeches/detail/who-directorgeneral-s-opening-remarks-at-the-media-briefing-on-covid-19---11- march-2020. Accessed in 2020 (March 11).
  7. 7. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-574. https://doi.org/ 10.1016/S0140-6736(20)30251-8.
  8. 8. Wong LE, Hawkins JE, Langness S, Murrell KL, Iris P, Sammann A. Where Are All the Patients? Addressing Covid-19 Fear to Encourage Sick Patients to Seek Emergency Care. NEJM Catalyst Innovations In Care Delivery. 2020. Available from: https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0193. Accessed in 2021 (Jul 1).

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

June 30, 2022

Submission Date

May 19, 2022

Acceptance Date

June 18, 2022

Published in Issue

Year 2022 Volume: 44 Number: 2

AMA
1.Uyan M, Tomas K, Kalcan S, Özdemir A, Demiral G, Pergel A. The Progress of Thyroid Cancer in The Covid 19 Period. CMJ. 2022;44(2):211-217. doi:10.7197/cmj.1118859